ArticleRadiology. Imaging cancer2026
Synthetic Phase-Sensitive Inversion Recovery and Extramural Vascular Invasion Scoring Systems for Vascular Invasion Detection and Metastasis Risk in Rectal Cancer.
Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To develop and validate a modified extramural vascular invasion (EMVI) scoring system with synthetic phase-sensitive inversion recovery (SyPSIR) images to improve vascular invasion detection and metastasis prediction in patients with rectal cancer. Materials and Methods Participants with rectal cancer were eligible for this single-center prospective study between October 2020 and June 2024, with follow-up intervals of 3-6 months (median follow-up, 23 months; range, 3-50 months). All participants underwent EMVI evaluation using conventional T2-weighted imaging-based and modified synthetic phase-sensitive inversion recovery-incorporated scoring systems, with diagnostic performance for pathologic EMVI detection evaluated against histopathology. Receiver operating characteristic curve analysis was used to evaluate the diagnostic performance of the pathologic EMVI results. Kaplan-Meier survival analysis and multivariable Cox regression analysis were used to compare the prognostic performance of the scoring systems, and a nomogram for metastasis risk stratification was developed. Results This study included 356 participants (mean age, 65 years ± 10 [SD]; 238 males) with rectal cancer (304 with pathologically confirmed EMVI). The modified EMVI scoring system demonstrated better diagnostic performance for pathologic EMVI detection than the conventional T2-weighted imaging system (sensitivity: 59%-80% vs 33%-49%; area under the receiver operating characteristic curve: 0.72-0.80 vs 0.59-0.68;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.